<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about NKTR</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Wed, 19 Jun 2013 17:44:37 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=NKTR" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/healthcare-stocks-in-late-retreat-nektar-therapeutics-reports-progress-with-addiction-treatment-cm254458">
      <guid isPermaLink="false">254458</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ik_Jg8ou2XU/healthcare-stocks-in-late-retreat-nektar-therapeutics-reports-progress-with-addiction-treatment-cm254458</link>
      <category>Investing</category>
      <category>Commodities</category>
      <title>Healthcare Stocks in Late Retreat; Nektar Therapeutics Reports Progress With Addiction Treatment</title>
      <description>Top Healthcare Stocks  JNJ -1.36%  PFE -0.22%  ABT -2.59%  MRK -0.10%  AMGN -1.61%  Healthcare stocks are lower heading into today's close with the NYSE Healthcare Sector Index dropping about&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Ik_Jg8ou2XU" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 19 Jun 2013 23:41:47 Z</pubDate>
      <a10:updated>2013-06-19T20:09:31Z</a10:updated>
      <author>MidnightTrader.com Staff</author>
      <nasdaq:tickers>NKTR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/healthcare-stocks-in-late-retreat-nektar-therapeutics-reports-progress-with-addiction-treatment-cm254458</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/sector-update-healthcare-cm254463">
      <guid isPermaLink="false">254463</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R0o32gWdA3o/sector-update-healthcare-cm254463</link>
      <category>Investing</category>
      <category>Commodities</category>
      <title>Sector Update: Healthcare</title>
      <description>Healthcare stocks are lower heading into today's close with the NYSE Healthcare Sector Index dropping about 1.1% and shares of healthcare companies in the S&amp;amp;P 500 also sliding around 1.1%&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/R0o32gWdA3o" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 19 Jun 2013 23:33:04 Z</pubDate>
      <a10:updated>2013-06-19T20:10:11Z</a10:updated>
      <author>MidnightTrader.com Staff</author>
      <nasdaq:tickers>NKTR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/sector-update-healthcare-cm254463</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/midday-market-update-lazboy-drops-on-q4-results-nektar-gains-cm254394">
      <guid isPermaLink="false">254394</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A6n_cl3XO8c/midday-market-update-lazboy-drops-on-q4-results-nektar-gains-cm254394</link>
      <category>Investing</category>
      <category>Commodities</category>
      <category>Economy</category>
      <category>International</category>
      <title>Mid-Day Market Update: La-Z-Boy Drops On Q4 Results, Nektar Gains</title>
      <description>Midway through trading Wednesday, the Dow traded down 0.05 percent to 15,309.86 while the NASDAQ declined 0.09 percent to 3,479.11. The S&amp;amp;P also fell, dropping 0.08 percent to 1,650.51.&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/A6n_cl3XO8c" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 19 Jun 2013 20:32:56 Z</pubDate>
      <a10:updated>2013-06-19T20:41:03Z</a10:updated>
      <author>Jake L&amp;#39;Ecuyer</author>
      <nasdaq:tickers>FDX</nasdaq:tickers>
      <nasdaq:tickers>KERX</nasdaq:tickers>
      <nasdaq:tickers>NKTR</nasdaq:tickers>
      <nasdaq:tickers>POOL</nasdaq:tickers>
      <nasdaq:tickers>TTEK</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/midday-market-update-lazboy-drops-on-q4-results-nektar-gains-cm254394</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/upside-position-adjusted-in-nektar-cm254247">
      <guid isPermaLink="false">254247</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AAjoe99JGjw/upside-position-adjusted-in-nektar-cm254247</link>
      <category>Investing</category>
      <category>Options</category>
      <title>Upside position adjusted in Nektar</title>
      <description>Nektar Therapeutics is holding a key level, and the bulls are sticking with the name.    optionMONSTER's Heat Seeker monitoring system detected the purchase of some 5,000 November 11 calls for&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/AAjoe99JGjw" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 19 Jun 2013 13:29:18 Z</pubDate>
      <a10:updated>2013-06-19T10:29:28Z</a10:updated>
      <author>David Russell</author>
      <nasdaq:tickers>NKTR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/upside-position-adjusted-in-nektar-cm254247</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/nektar-presents-data-on-oncology-candidates-analyst-blog-cm251133">
      <guid isPermaLink="false">251133</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K9oYNvKZY70/nektar-presents-data-on-oncology-candidates-analyst-blog-cm251133</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Nektar Presents Data on Oncology Candidates - Analyst Blog</title>
      <description>Nektar Therapeutics  (  NKTR  ) recently  presented encouraging preclinical data on NKTR-214 at the 2013  annual meeting of the American Society of Clinical Oncology (ASCO).  Nektar is&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/K9oYNvKZY70" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 06 Jun 2013 01:30:26 Z</pubDate>
      <a10:updated>2013-06-05T21:30:33Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ASCO</nasdaq:tickers>
      <nasdaq:tickers>CBST</nasdaq:tickers>
      <nasdaq:tickers>CTC</nasdaq:tickers>
      <nasdaq:tickers>JAZZ</nasdaq:tickers>
      <nasdaq:tickers>NKTR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/nektar-presents-data-on-oncology-candidates-analyst-blog-cm251133</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/data-on-astrazenecas-naloxegol-analyst-blog-cm248374">
      <guid isPermaLink="false">248374</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oI9qg_W_YNA/data-on-astrazenecas-naloxegol-analyst-blog-cm248374</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Data on AstraZeneca's Naloxegol - Analyst Blog</title>
      <description>AstraZeneca  (  AZN  ) recently presented data on naloxegol (25 mg once daily) from two pivotal phase III studies (KODIAC-04 and -05) at the Digestive Disease Week (DDW) meeting. Top-line&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/oI9qg_W_YNA" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 24 May 2013 02:28:59 Z</pubDate>
      <a10:updated>2013-05-23T23:28:52Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AZN</nasdaq:tickers>
      <nasdaq:tickers>NKTR</nasdaq:tickers>
      <nasdaq:tickers>SLXP</nasdaq:tickers>
      <nasdaq:tickers>SNTS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/data-on-astrazenecas-naloxegol-analyst-blog-cm248374</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/after-hours-most-active-for-may-23-2013-df-df-pfe-wwav-kwk-ksu-nktr-intc-qqq-symc-siri-csco-cm248343">
      <guid isPermaLink="false">248343</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pD7t11zS6dg/after-hours-most-active-for-may-23-2013-df-df-pfe-wwav-kwk-ksu-nktr-intc-qqq-symc-siri-csco-cm248343</link>
      <category>News Headlines</category>
      <category>After Hours Most Active</category>
      <title>After Hours Most Active for May 23, 2013 :  DF, DF$, PFE, WWAV$, KWK, KSU, NKTR, INTC, QQQ, SYMC, SIRI, CSCO</title>
      <description>The  NASDAQ 100 After Hours Indicator  is up 1.22 to 2,992.67. The total After hours volume is currently 33,514,505 shares traded.    The following are the   most active stocks for the after&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/pD7t11zS6dg" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 24 May 2013 00:43:18 Z</pubDate>
      <a10:updated>2013-05-23T21:05:02Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>CSCO</nasdaq:tickers>
      <nasdaq:tickers>DF</nasdaq:tickers>
      <nasdaq:tickers>INTC</nasdaq:tickers>
      <nasdaq:tickers>KSU</nasdaq:tickers>
      <nasdaq:tickers>KWK</nasdaq:tickers>
      <nasdaq:tickers>NKTR</nasdaq:tickers>
      <nasdaq:tickers>PFE</nasdaq:tickers>
      <nasdaq:tickers>QQQ</nasdaq:tickers>
      <nasdaq:tickers>SIRI</nasdaq:tickers>
      <nasdaq:tickers>SYMC</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/after-hours-most-active-for-may-23-2013-df-df-pfe-wwav-kwk-ksu-nktr-intc-qqq-symc-siri-csco-cm248343</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/nektar-posts-wider-loss-maintains-view-analyst-blog-cm246374">
      <guid isPermaLink="false">246374</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FVXecK6wqno/nektar-posts-wider-loss-maintains-view-analyst-blog-cm246374</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Nektar Posts Wider Loss, Maintains View - Analyst Blog</title>
      <description>Nektar Therapeutics  (  NKTR  ) reported a loss of 48 cents per share in the first quarter of 2013, wider than the year-ago loss of 34 cents and the Zacks Consensus Estimate of a loss of 41&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/FVXecK6wqno" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 15 May 2013 20:26:01 Z</pubDate>
      <a10:updated>2013-05-15T17:32:36Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>JAZZ</nasdaq:tickers>
      <nasdaq:tickers>NKTR</nasdaq:tickers>
      <nasdaq:tickers>RHHBY</nasdaq:tickers>
      <nasdaq:tickers>UCBJF</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/nektar-posts-wider-loss-maintains-view-analyst-blog-cm246374</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/positive-data-on-nektars-nktr214-analyst-blog-cm234789">
      <guid isPermaLink="false">234789</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eWVFv6OPtCc/positive-data-on-nektars-nktr214-analyst-blog-cm234789</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Positive Data on Nektar's NKTR-214 - Analyst Blog</title>
      <description>Nektar Therapeutics  (  NKTR  ) recently presented positive data from a preclinical study on NKTR-214. NKTR-214 targets the interleukin-2 (IL-2) receptor complex and is being developed or the&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/eWVFv6OPtCc" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 09 Apr 2013 02:08:18 Z</pubDate>
      <a10:updated>2013-04-08T23:11:14Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>NKTR</nasdaq:tickers>
      <nasdaq:tickers>RHHBY</nasdaq:tickers>
      <nasdaq:tickers>SNY</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/positive-data-on-nektars-nktr214-analyst-blog-cm234789</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/nektar-loss-widens-gives-guidance-analyst-blog-cm224547">
      <guid isPermaLink="false">224547</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mtnVRe8sf2o/nektar-loss-widens-gives-guidance-analyst-blog-cm224547</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Nektar Loss Widens, Gives Guidance - Analyst Blog</title>
      <description>Nektar Therapeutics  (  NKTR  ) reported a loss of 46 cents per share in the fourth quarter of 2012, wider than the year-ago loss of 33 cents and the Zacks Consensus Estimate of a loss of 45&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/mtnVRe8sf2o" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 07 Mar 2013 22:41:01 Z</pubDate>
      <a10:updated>2013-03-07T19:01:09Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ARRY</nasdaq:tickers>
      <nasdaq:tickers>NKTR</nasdaq:tickers>
      <nasdaq:tickers>RHHBY</nasdaq:tickers>
      <nasdaq:tickers>UCBJF</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/nektar-loss-widens-gives-guidance-analyst-blog-cm224547</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/azn-reports-naloxegol-safety-data-analyst-blog-cm221840">
      <guid isPermaLink="false">221840</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bfLs1x62MH4/azn-reports-naloxegol-safety-data-analyst-blog-cm221840</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>AZN Reports Naloxegol Safety Data  - Analyst Blog</title>
      <description>AstraZeneca  (  AZN  ) recently announced long-term safety data from a phase III study (KODIAC-08) evaluating the use of naloxegol (25 mg once daily) in non-cancer related pain and&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/bfLs1x62MH4" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 28 Feb 2013 02:28:46 Z</pubDate>
      <a10:updated>2013-02-27T22:32:17Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AZN</nasdaq:tickers>
      <nasdaq:tickers>BAYRY</nasdaq:tickers>
      <nasdaq:tickers>LLY</nasdaq:tickers>
      <nasdaq:tickers>NKTR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/azn-reports-naloxegol-safety-data-analyst-blog-cm221840</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/midday-market-update-markets-slump-facebook-remains-up-on-massive-volume-cm189902">
      <guid isPermaLink="false">189902</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/imfi2eC8C6M/midday-market-update-markets-slump-facebook-remains-up-on-massive-volume-cm189902</link>
      <category>Investing</category>
      <category>Commodities</category>
      <category>Earnings</category>
      <category>Economy</category>
      <category>International</category>
      <title>Mid-Day Market Update: Markets Slump; Facebook Remains Up on Massive Volume</title>
      <description>Mid-way through trading Wednesday, the Dow traded down 0.69 percent to 12,668.75 while the NASDAQ fell 0.38 percent to 2,872.87. The S&amp;amp;P also fell, decreasing 0.54 percent to 1,367.09.&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/imfi2eC8C6M" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 15 Nov 2012 00:14:18 Z</pubDate>
      <a10:updated>2012-11-14T19:23:54Z</a10:updated>
      <author>Benzinga</author>
      <nasdaq:tickers>ANF</nasdaq:tickers>
      <nasdaq:tickers>BGCP</nasdaq:tickers>
      <nasdaq:tickers>CSCO</nasdaq:tickers>
      <nasdaq:tickers>IAG</nasdaq:tickers>
      <nasdaq:tickers>NKTR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/midday-market-update-markets-slump-facebook-remains-up-on-massive-volume-cm189902</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/afterhours-earnings-report-for-november-13-2012-csco-iag-wwd-hmin-wair-agro-svm-nktr-ga-gff-renn-gol-cm189518">
      <guid isPermaLink="false">189518</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JKPSP_JJj7w/afterhours-earnings-report-for-november-13-2012-csco-iag-wwd-hmin-wair-agro-svm-nktr-ga-gff-renn-gol-cm189518</link>
      <category>News Headlines</category>
      <category>Earnings</category>
      <title>After-Hours Earnings Report for November 13, 2012 :  CSCO, IAG, WWD, HMIN, WAIR, AGRO, SVM, NKTR, GA, GFF, RENN, GOL</title>
      <description>The following companies are expected to report earnings after hours on 11/13/2012. Visit our  Earnings Calendar  for a full list of expected earnings releases.   Cisco Systems, Inc.  (  CSCO  )&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/JKPSP_JJj7w" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 14 Nov 2012 00:00:03 Z</pubDate>
      <a10:updated>2012-11-13T19:23:53Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>AGRO</nasdaq:tickers>
      <nasdaq:tickers>CSCO</nasdaq:tickers>
      <nasdaq:tickers>GA</nasdaq:tickers>
      <nasdaq:tickers>GFF</nasdaq:tickers>
      <nasdaq:tickers>GOL</nasdaq:tickers>
      <nasdaq:tickers>HMIN</nasdaq:tickers>
      <nasdaq:tickers>IAG</nasdaq:tickers>
      <nasdaq:tickers>NKTR</nasdaq:tickers>
      <nasdaq:tickers>RENN</nasdaq:tickers>
      <nasdaq:tickers>SVM</nasdaq:tickers>
      <nasdaq:tickers>WAIR</nasdaq:tickers>
      <nasdaq:tickers>WWD</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/afterhours-earnings-report-for-november-13-2012-csco-iag-wwd-hmin-wair-agro-svm-nktr-ga-gff-renn-gol-cm189518</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/premarket-most-active-for-nov-12-2012-tie-un-bac-gild-mt-clvs-fb-jef-grpn-dcm-nktr-qqq-cm189017">
      <guid isPermaLink="false">189017</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xZjcA65uRRI/premarket-most-active-for-nov-12-2012-tie-un-bac-gild-mt-clvs-fb-jef-grpn-dcm-nktr-qqq-cm189017</link>
      <category>News Headlines</category>
      <category>Pre-market Most Active</category>
      <title>Pre-Market Most Active for Nov 12, 2012 :  TIE, UN, BAC, GILD, MT, CLVS, FB, JEF, GRPN, DCM, NKTR, QQQ</title>
      <description>The  NASDAQ 100 Pre-Market Indicator  is to 2,596.32. The total Pre-Market volume is currently 7,375,186 shares traded.    The following are the   most active stocks for the pre-market session  :&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/xZjcA65uRRI" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 12 Nov 2012 18:39:57 Z</pubDate>
      <a10:updated>2012-11-12T13:56:54Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>BAC</nasdaq:tickers>
      <nasdaq:tickers>CLVS</nasdaq:tickers>
      <nasdaq:tickers>DCM</nasdaq:tickers>
      <nasdaq:tickers>FB</nasdaq:tickers>
      <nasdaq:tickers>GILD</nasdaq:tickers>
      <nasdaq:tickers>GRPN</nasdaq:tickers>
      <nasdaq:tickers>JEF</nasdaq:tickers>
      <nasdaq:tickers>MT</nasdaq:tickers>
      <nasdaq:tickers>NKTR</nasdaq:tickers>
      <nasdaq:tickers>QQQ</nasdaq:tickers>
      <nasdaq:tickers>TIE</nasdaq:tickers>
      <nasdaq:tickers>UN</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/premarket-most-active-for-nov-12-2012-tie-un-bac-gild-mt-clvs-fb-jef-grpn-dcm-nktr-qqq-cm189017</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/largest-option-buying-in-equities-so-far-cm188361">
      <guid isPermaLink="false">188361</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fw-HIe8Ij1s/largest-option-buying-in-equities-so-far-cm188361</link>
      <category>Investing</category>
      <category>Options</category>
      <title>Largest option buying in equities so far</title>
      <description>Nearing the halfway mark in today's session, here are the individual equity names with the most call and put buying on optionMONSTER's ActionTracker data system.    Nektar Therapeutics (NKTR):&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/fw-HIe8Ij1s" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 08 Nov 2012 21:26:56 Z</pubDate>
      <a10:updated>2012-11-08T17:36:49Z</a10:updated>
      <author>David Russell</author>
      <nasdaq:tickers>AIG</nasdaq:tickers>
      <nasdaq:tickers>C</nasdaq:tickers>
      <nasdaq:tickers>INTC</nasdaq:tickers>
      <nasdaq:tickers>NKTR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/largest-option-buying-in-equities-so-far-cm188361</feedburner:origLink></item>
  </channel>
</rss>
